Would really like to hear David advise tomorrow, that near term funding (non dilutive and commercial contract revenue) will avoid the need for another cap raise before EV1 revenue kicks in as planned in the table.
Looks very borderline from what Im reading.
Thoughts??
- Forums
- ASX - By Stock
- ADO
- Ann: FY2024 Full Year Results - Investor Presentation
ADO
anteotech ltd
Add to My Watchlist
7.14%
!
1.5¢

Ann: FY2024 Full Year Results - Investor Presentation, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.5¢ |
Change
0.001(7.14%) |
Mkt cap ! $40.57M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $3.98K | 267.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1623476 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 4204208 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1623476 | 0.014 |
8 | 1809222 | 0.013 |
8 | 2283372 | 0.012 |
7 | 2658674 | 0.011 |
7 | 3309000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 4204208 | 14 |
0.016 | 1434727 | 3 |
0.017 | 733673 | 7 |
0.018 | 1186369 | 5 |
0.019 | 1117333 | 8 |
Last trade - 11.59am 27/06/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online